14:00 - 14:30 Opening & Welcome

14:30 - 16:00 Session 1a - Novel RNA biology and epitranscriptomics

• Crosstalk between Epitranscriptomics and Epigenomics in Hematological Malignancies
  Manel Esteller (Spain)
• Targeting RNA modifications in acute myeloid leukaemia
  Kamil Kranc (United Kingdom)
  
• Lecture
  Gidi Rechavi (Israel)
  

16:00 - 16:30 Coffee break

16:30 - 17:15 Session 1b - Novel RNA biology and epitranscriptomics

• Abstract presentations

17:15 - 18:00 Opening talk

• How to downplay Evil transcription in AML
  Ruud Delwel (The Netherlands)
  

18:00 - 18:30 Poster pitch 1

• 5-minute flash talks from top poster presenters

18:30 - 20:00 Poster walk with reception

20:00 - 22:00 Dinner

08:45 - 10:15 Session 2a - Transcriptional control in hematopoiesis and hematological malignancies

• Transcriptional Control of Blood Stem/Progenitor Cells
  Bertie Göttgens (United Kingdom)
• Metabolism Programs Regulating Myeloid Lineage Specification
  Leila Perie (France)
• Charting early lymphoma formation from the epigenomics perspective
  Renée Beekman (Spain)

10:15 - 11:00 Session 2b - Transcriptional control in hematopoiesis and hematological malignancies

• Abstract presentations

11:00 - 11:30 Coffee break

11:30 - 12:15 HemaSphere Session

12:15 - 13:00 Data vizualization in publishing

• Lecture
  Isabel Romero Calvo (Spain)

13:00 - 14:00 Lunch break

14:00 - 14:30 Poster pitch 2

• 5-minute flash talks from top poster presenters

14:30 - 16:00 Session 3a - Consequences of mutations in chromatin regulators

• Epigenetic Regulators in Clonal Hematopoiesis
  Margaret Goodell (United States)
• Clonal hematopoiesis and myelodysplastic syndromes
  Toshio Kitamura (Japan)
• Biology and therapeutic targeting of cohesin mutations in myeloid malignancies
  Zuzana Tothova (United States)

16:00 - 16:45 Coffee break & poster browsing

16:45 - 17:30 Session 3b - Consequences of mutations in chromatin regulators

• Abstract presentations

17:30 - 19:00 Poster walk with reception 

20:00 - 22:00 Dinner

08:45 - 10:15 Session 4a - 3D chromatin architecture and nuclear organization

• Network approaches to study 3D chromatin networks in differentiation and cancer
  Vera Pancaldi (France)
• Modulation of 3D chromatin structures to support tumor evolution
  Elisa Oricchio (Switzerland)
• Enhancer hijacking in AML
  Christopher Plass (Germany)

10:15 - 11:00 Session 4b - 3D chromatin architecture and nuclear organization

• Abstract presentations

11:00 - 11:45 Coffee break & poster browsing

11:45 - 13:15 Session 5a - Targeting chromatin regulators in hematology

• Targeting Fusion Oncoproteins in Pediatric Leukemia
  Florian Grebien (Austria)
• Mechanisms and therapy of oncogenic gene expression in AML
  Alex Kentsis (United States)
• Targeting the onco-niche in myeloproliferative neoplasms
  Marta Derecka (United States)

13:15 - 14:00 Lunch break

14:30 - 22:00 Activity with dinner

08:30 - 09:15 Session 5b - Targeting chromatin regulators in hematology

• Abstract presentations

09:15 - 10:45 Session 6a - Non-coding genome

• RNA sensing during developmental transitions
  Eirini Trompouki (France)
• Epigenetic dysregulation of the repeatome in cancer
  Özgen Deniz (United Kingdom)
• Activation of oncogenes through noncoding alterations in T-ALL
  Marc Mansour (United Kingdom)

10:45 - 11:15 Coffee break

11:15 - 12:00 Session 6b - Non-coding genome

• Abstract presentations

12:00 - 12:45 Closing talk

• Regulation of hematopoietic stem cell dormancy
  Nina Cabezas Wallscheid (Germany)

12:45 - 13:15 Closing ceremony & Awards

13:15 - 14:00 Farewell lunch & Departure